Medicare AdvantageCoverageMedium impact
MA07.050n, Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies
Independence Blue Cross·Neurology, PM&R (Physical Medicine & Rehab), Orthopedics +1 more·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.050n for Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies has been updated with an effective date of October 1, 2025. This policy change affects electrodiagnostic testing procedures commonly used in neurology, orthopedics, and physical medicine practices.
Action Required
By October 1, 2025: Billing team must review the complete updated policy MA07.050n at the IBX medical policy website to understand specific changes to EMG and nerve conduction study requirements for Medicare Advantage patients. Update billing procedures, prior authorization requirements, and documentation standards according to the new policy guidelines.